Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Molecular basis for HLA-DQ associations with IDDM.

    Nepom GT, Kwok WW.

    Diabetes. 1998 Aug;47(8):1177-84. Review.PMID: 9703314 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HLA class II sequences and genetic susceptibility to insulin dependent diabetes mellitus.

    Erlich HA.

    Baillieres Clin Endocrinol Metab. 1991 Sep;5(3):395-411. Review.PMID: 1909860 [PubMed - indexed for MEDLINE]Related articles

    3.

    HLA class II polymorphism and genetic susceptibility to insulin-dependent diabetes mellitus.

    Erlich HA.

    Curr Top Microbiol Immunol. 1990;164:41-55. Review.PMID: 2127392 [PubMed - indexed for MEDLINE]Related articles

    4.

    Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus.

    Thorsby E, Rønningen KS.

    Ann Med. 1992 Dec;24(6):523-31. Review.PMID: 1485949 [PubMed - indexed for MEDLINE]Related articles

    5.

    Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.

    Thorsby E, Rønningen KS.

    Diabetologia. 1993 May;36(5):371-7. Review.PMID: 8314439 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Genetic susceptibility of insulin-dependent diabetes]

    Semana G.

    Ann Endocrinol (Paris). 1992;53(3):73-7. Review. French. PMID: 1295434 [PubMed - indexed for MEDLINE]Related articles

    8.

    Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.

    Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S.

    Diabetes. 1999 Oct;48(10):1937-47.PMID: 10512357 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease.

    Gregersen PK.

    Lab Invest. 1989 Jul;61(1):5-19. Review.PMID: 2664347 [PubMed - indexed for MEDLINE]Related articles

    10.

    Autoimmune disorders in diabetes.

    Boitard C, Debray-Sachs M, Bach JF.

    Adv Nephrol Necker Hosp. 1986;15:281-305. Review.PMID: 3082114 [PubMed - indexed for MEDLINE]Related articles

    11.

    Molecular aspects of HLA class II alphabeta heterodimers associated with IDDM susceptibility and protection.

    Ettinger RA, Nepom GT.

    Rev Immunogenet. 2000;2(1):88-94. Review.PMID: 11324697 [PubMed - indexed for MEDLINE]Related articles

    12.

    Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians.

    Nishimura Y, Kanai T, Oiso M, Tabata H, Ito H, Kira J, Chen YZ, Matsushita S.

    Int J Cardiol. 1998 Oct 1;66 Suppl 1:S93-104; discussion S105. Review.PMID: 9951808 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases]

    Nishimura Y.

    Nippon Rinsho. 1997 Jun;55(6):1384-96. Review. Japanese. PMID: 9200922 [PubMed - indexed for MEDLINE]Related articles

    15.

    A unified hypothesis for the complex genetics of HLA associations with IDDM.

    Nepom GT.

    Diabetes. 1990 Oct;39(10):1153-7. Review.PMID: 2210067 [PubMed - indexed for MEDLINE]Related articles

    16.

    Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.

    Nishimura Y, Oiso M, Fujisao S, Kanai T, Kira J, Chen YZ, Matsushita S.

    Int Rev Immunol. 1998;17(5-6):229-62. Review.PMID: 10036633 [PubMed - indexed for MEDLINE]Related articles

    18.

    Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.

    Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.

    Diabetologia. 1995 Dec;38(12):1493-5. No abstract available. PMID: 8786033 [PubMed - indexed for MEDLINE]Related articles

    19.

    HLA class II transgenic mice as models of human diseases.

    Taneja V, David CS.

    Immunol Rev. 1999 Jun;169:67-79. Review.PMID: 10450509 [PubMed - indexed for MEDLINE]Related articles

    20.

    Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.

    Abraham RS, Wen L, Marietta EV, David CS.

    J Immunol. 2001 Jan 15;166(2):1370-9.PMID: 11145722 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data